FDA/CMS Device Trade Secret Memo Added To Regulatory Reform Wish List

FDA and CMS should issue a memorandum of understanding on maintaining confidentiality and trade secrets during collaborations between the agencies in evaluating new devices, according to the HHS Secretary's Advisory Committee on Regulatory Reform